Pay in 4 interest-free payments of $12.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
PO) significantly augments plasma insulin levels and reduces fasting hyperglycemia in male Zucker diabetic fatty rats
(2012) Genes Dev
A Novel Anti-inflammatory Role of GPR120 in Intestinal Epithelial Cells
2015 Jul-Aug
Degrasyn activates proteasomal-dependent degradation of c-Myc
GSK2801 - Bromodomain BAZ2A/B Inhibitor. CAS# 1619994-68-1 size:2 mg solid PO) significantly augments plasma insulinGSK2801, CAS No. 1619994 68 1, is a potent, selective and cell permeable inhibitor of the bromodomain BAZ2A and BAZ2B. It binds to BAZ2 bromodomains with dissociation constants (KD) of 136 and 257 nM for BAZ2B and BAZ2A, respectively. Crystal structures of GSK2801 demonstrated a canonical acetyl lysine competitive binding mode. It does not interact with the bromodomains of BRD4(BD1), CREBBP, TRIM24 TIF1, PB1(BD5), PCAF, or ATAD2. A pharmacokinetic
US$ 180.00
US$ 72.00
US$ 38.00
US$ 38.00